Core Laboratories N.V. (NYSE:CLB) was upgraded by equities research analysts at Credit Suisse Group from a “neutral” rating to an “outperform” rating in a research report issued on Thursday. The brokerage currently has a $110.00 target price on the oil and gas company’s stock. Credit Suisse Group’s price target suggests a potential upside of 22.75% from the company’s previous close. The analysts noted that the move was a valuation call.

Several other equities analysts have also recently issued reports on CLB. ValuEngine cut shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a research note on Tuesday, June 6th. Zacks Investment Research upgraded shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $116.00 target price for the company in a research note on Monday, June 12th. BidaskClub upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 13th. Royal Bank Of Canada set a $145.00 target price on shares of Core Laboratories N.V. and gave the company a “buy” rating in a research note on Saturday, June 17th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $130.00 target price (down from $150.00) on shares of Core Laboratories N.V. in a research note on Wednesday, June 21st. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $116.75.

Core Laboratories N.V. (CLB) opened at 89.61 on Thursday. Core Laboratories N.V. has a 1-year low of $87.83 and a 1-year high of $125.83. The company has a 50-day moving average of $98.61 and a 200-day moving average of $106.75. The stock has a market capitalization of $3.96 billion, a price-to-earnings ratio of 54.98 and a beta of 1.60.

Core Laboratories N.V. (NYSE:CLB) last posted its earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm had revenue of $163.90 million during the quarter, compared to analysts’ expectations of $168.23 million. During the same period in the previous year, the business posted $0.35 EPS. The business’s revenue was up 10.7% compared to the same quarter last year. Analysts anticipate that Core Laboratories N.V. will post $2.09 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Credit Suisse Group Upgrades Core Laboratories N.V. (CLB) to “Outperform”” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/26/credit-suisse-group-upgrades-core-laboratories-n-v-clb-to-outperform.html.

Large investors have recently added to or reduced their stakes in the company. Parallel Advisors LLC raised its stake in Core Laboratories N.V. by 33.4% in the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock worth $101,000 after buying an additional 223 shares during the last quarter. Quantbot Technologies LP acquired a new stake in Core Laboratories N.V. during the first quarter worth about $106,000. The Manufacturers Life Insurance Company raised its stake in Core Laboratories N.V. by 63.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock worth $114,000 after buying an additional 439 shares during the last quarter. Advisory Services Network LLC acquired a new stake in Core Laboratories N.V. during the first quarter worth about $118,000. Finally, FNY Managed Accounts LLC acquired a new stake in Core Laboratories N.V. during the first quarter worth about $123,000.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Stock Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related stocks with our FREE daily email newsletter.